nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—gout	0.432	1	CbGaD
Lansoprazole—CYP2C8—Naproxen—gout	0.0313	0.0828	CbGbCtD
Lansoprazole—CYP1A2—Naproxen—gout	0.0243	0.0641	CbGbCtD
Lansoprazole—ABCG2—Hydrocortisone—gout	0.024	0.0633	CbGbCtD
Lansoprazole—CYP2C8—Colchicine—gout	0.0237	0.0628	CbGbCtD
Lansoprazole—CYP2C9—Naproxen—gout	0.0219	0.0578	CbGbCtD
Lansoprazole—CYP2C8—Probenecid—gout	0.0213	0.0562	CbGbCtD
Lansoprazole—CYP2C19—Probenecid—gout	0.0178	0.0471	CbGbCtD
Lansoprazole—CYP2C19—Indomethacin—gout	0.0174	0.0459	CbGbCtD
Lansoprazole—CYP2C9—Colchicine—gout	0.0166	0.0438	CbGbCtD
Lansoprazole—ABCB1—Colchicine—gout	0.0161	0.0425	CbGbCtD
Lansoprazole—CYP2C9—Probenecid—gout	0.0148	0.0392	CbGbCtD
Lansoprazole—CYP2C9—Indomethacin—gout	0.0144	0.0382	CbGbCtD
Lansoprazole—ABCB1—Probenecid—gout	0.0144	0.038	CbGbCtD
Lansoprazole—ABCB1—Methylprednisolone—gout	0.0142	0.0375	CbGbCtD
Lansoprazole—ABCB1—Indomethacin—gout	0.014	0.037	CbGbCtD
Lansoprazole—CYP2C8—Hydrocortisone—gout	0.0128	0.0337	CbGbCtD
Lansoprazole—CYP2C19—Prednisone—gout	0.0107	0.0282	CbGbCtD
Lansoprazole—CYP3A4—Colchicine—gout	0.00963	0.0255	CbGbCtD
Lansoprazole—ABCB1—Prednisolone—gout	0.00911	0.0241	CbGbCtD
Lansoprazole—ABCB1—Hydrocortisone—gout	0.00864	0.0228	CbGbCtD
Lansoprazole—CYP3A4—Probenecid—gout	0.00862	0.0228	CbGbCtD
Lansoprazole—ABCB1—Prednisone—gout	0.0086	0.0227	CbGbCtD
Lansoprazole—CYP3A4—Methylprednisolone—gout	0.00851	0.0225	CbGbCtD
Lansoprazole—CYP3A4—Prednisolone—gout	0.00546	0.0144	CbGbCtD
Lansoprazole—CYP3A4—Hydrocortisone—gout	0.00517	0.0137	CbGbCtD
Lansoprazole—CYP3A4—Prednisone—gout	0.00515	0.0136	CbGbCtD
Lansoprazole—ATP4B—Ion channel transport—SLC17A3—gout	0.00196	0.11	CbGpPWpGaD
Lansoprazole—ATP4A—Ion channel transport—SLC17A3—gout	0.00175	0.0982	CbGpPWpGaD
Lansoprazole—Pantoprazole—ABCG2—gout	0.00139	0.355	CrCbGaD
Lansoprazole—Rabeprazole—ABCG2—gout	0.00139	0.355	CrCbGaD
Lansoprazole—Omeprazole—ABCG2—gout	0.00113	0.29	CrCbGaD
Lansoprazole—ABCB1—Abacavir transmembrane transport—ABCG2—gout	0.00108	0.0604	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC17A3—gout	0.000683	0.0383	CbGpPWpGaD
Lansoprazole—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.000618	0.0347	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC17A3—gout	0.000609	0.0342	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC17A1—gout	0.000557	0.0312	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC22A11—gout	0.000557	0.0312	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC22A11—gout	0.000496	0.0278	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC17A1—gout	0.000496	0.0278	CbGpPWpGaD
Lansoprazole—CYP4A11—NRF2 pathway—SLC2A9—gout	0.000435	0.0244	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC22A12—gout	0.000422	0.0237	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—SLC2A9—gout	0.000392	0.022	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC22A12—gout	0.000376	0.0211	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—SLC2A9—gout	0.00035	0.0196	CbGpPWpGaD
Lansoprazole—MAPT—MAPK Signaling Pathway—CASP1—gout	0.000308	0.0173	CbGpPWpGaD
Lansoprazole—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000291	0.0163	CbGpPWpGaD
Lansoprazole—CYP1B1—Endogenous sterols—POMC—gout	0.000276	0.0155	CbGpPWpGaD
Lansoprazole—ATP4B—Transmembrane transport of small molecules—ABCG2—gout	0.000206	0.0116	CbGpPWpGaD
Lansoprazole—CYP4A11—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000199	0.0112	CbGpPWpGaD
Lansoprazole—ATP4A—Transmembrane transport of small molecules—ABCG2—gout	0.000184	0.0103	CbGpPWpGaD
Lansoprazole—CYP2C18—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000174	0.00977	CbGpPWpGaD
Lansoprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000173	0.00973	CbGpPWpGaD
Lansoprazole—CYP4A11—Phase 1 - Functionalization of compounds—POMC—gout	0.000162	0.00906	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	0.000142	0.00797	CbGpPWpGaD
Lansoprazole—CYP2C18—Phase 1 - Functionalization of compounds—POMC—gout	0.000141	0.00792	CbGpPWpGaD
Lansoprazole—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	0.000137	0.00766	CbGpPWpGaD
Lansoprazole—CYP1B1—Cytochrome P450 - arranged by substrate type—POMC—gout	0.000128	0.0072	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	0.000116	0.0065	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	0.000116	0.0065	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—BCKDHA—gout	0.000114	0.00637	CbGpPWpGaD
Lansoprazole—CYP1B1—Phase 1 - Functionalization of compounds—POMC—gout	0.000104	0.00584	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—BCKDHA—gout	9.93e-05	0.00557	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PRPS2—gout	9.26e-05	0.00519	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—HPRT1—gout	9.26e-05	0.00519	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—PRPS1—gout	9.26e-05	0.00519	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	8.78e-05	0.00493	CbGpPWpGaD
Lansoprazole—CYP4A11—Biological oxidations—POMC—gout	8.58e-05	0.00481	CbGpPWpGaD
Lansoprazole—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	8.16e-05	0.00458	CbGpPWpGaD
Lansoprazole—Acute coronary syndrome—Hydrocortisone—gout	8.11e-05	0.000483	CcSEcCtD
Lansoprazole—CYP2C18—Metabolism—PRPS1—gout	8.09e-05	0.00454	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—HPRT1—gout	8.09e-05	0.00454	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—PRPS2—gout	8.09e-05	0.00454	CbGpPWpGaD
Lansoprazole—Neuropathy peripheral—Hydrocortisone—gout	8.07e-05	0.00048	CcSEcCtD
Lansoprazole—Myocardial infarction—Hydrocortisone—gout	8.07e-05	0.00048	CcSEcCtD
Lansoprazole—Rash—Indomethacin—gout	8.05e-05	0.000479	CcSEcCtD
Lansoprazole—Dermatitis—Indomethacin—gout	8.05e-05	0.000479	CcSEcCtD
Lansoprazole—Urticaria—Naproxen—gout	8.04e-05	0.000478	CcSEcCtD
Lansoprazole—Headache—Indomethacin—gout	8e-05	0.000476	CcSEcCtD
Lansoprazole—Body temperature increased—Naproxen—gout	8e-05	0.000476	CcSEcCtD
Lansoprazole—Abdominal pain—Naproxen—gout	8e-05	0.000476	CcSEcCtD
Lansoprazole—Nausea—Colchicine—gout	7.98e-05	0.000475	CcSEcCtD
Lansoprazole—Osteoarthritis—Prednisone—gout	7.94e-05	0.000473	CcSEcCtD
Lansoprazole—Gastrointestinal haemorrhage—Prednisone—gout	7.94e-05	0.000473	CcSEcCtD
Lansoprazole—Diarrhoea—Allopurinol—gout	7.93e-05	0.000472	CcSEcCtD
Lansoprazole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—gout	7.91e-05	0.00443	CbGpPWpGaD
Lansoprazole—Weight increased—Methylprednisolone—gout	7.89e-05	0.00047	CcSEcCtD
Lansoprazole—Affect lability—Prednisone—gout	7.82e-05	0.000465	CcSEcCtD
Lansoprazole—Infestation—Methylprednisolone—gout	7.73e-05	0.00046	CcSEcCtD
Lansoprazole—Infestation NOS—Methylprednisolone—gout	7.73e-05	0.00046	CcSEcCtD
Lansoprazole—Bradycardia—Prednisolone—gout	7.7e-05	0.000458	CcSEcCtD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	7.68e-05	0.00431	CbGpPWpGaD
Lansoprazole—Face oedema—Prednisone—gout	7.67e-05	0.000456	CcSEcCtD
Lansoprazole—Dizziness—Allopurinol—gout	7.66e-05	0.000456	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Methylprednisolone—gout	7.62e-05	0.000454	CcSEcCtD
Lansoprazole—Nausea—Indomethacin—gout	7.59e-05	0.000451	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Methylprednisolone—gout	7.58e-05	0.000451	CcSEcCtD
Lansoprazole—Myocardial infarction—Methylprednisolone—gout	7.58e-05	0.000451	CcSEcCtD
Lansoprazole—Mood swings—Prednisone—gout	7.53e-05	0.000448	CcSEcCtD
Lansoprazole—Bradycardia—Hydrocortisone—gout	7.52e-05	0.000448	CcSEcCtD
Lansoprazole—CYP2C18—Biological oxidations—POMC—gout	7.5e-05	0.00421	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Naproxen—gout	7.45e-05	0.000444	CcSEcCtD
Lansoprazole—Sweating—Methylprednisolone—gout	7.41e-05	0.000441	CcSEcCtD
Lansoprazole—Vomiting—Allopurinol—gout	7.37e-05	0.000439	CcSEcCtD
Lansoprazole—Hallucination—Hydrocortisone—gout	7.35e-05	0.000437	CcSEcCtD
Lansoprazole—CYP1B1—Metabolism—BCKDHA—gout	7.32e-05	0.0041	CbGpPWpGaD
Lansoprazole—Rash—Allopurinol—gout	7.31e-05	0.000435	CcSEcCtD
Lansoprazole—Dermatitis—Allopurinol—gout	7.3e-05	0.000434	CcSEcCtD
Lansoprazole—Visual impairment—Prednisolone—gout	7.29e-05	0.000434	CcSEcCtD
Lansoprazole—Dry skin—Prednisone—gout	7.28e-05	0.000433	CcSEcCtD
Lansoprazole—Headache—Allopurinol—gout	7.26e-05	0.000432	CcSEcCtD
Lansoprazole—Asthenia—Naproxen—gout	7.26e-05	0.000432	CcSEcCtD
Lansoprazole—Connective tissue disorder—Hydrocortisone—gout	7.26e-05	0.000432	CcSEcCtD
Lansoprazole—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	7.25e-05	0.00407	CbGpPWpGaD
Lansoprazole—Hypokalaemia—Prednisone—gout	7.23e-05	0.00043	CcSEcCtD
Lansoprazole—Pruritus—Naproxen—gout	7.16e-05	0.000426	CcSEcCtD
Lansoprazole—Bradycardia—Methylprednisolone—gout	7.06e-05	0.00042	CcSEcCtD
Lansoprazole—Muscular weakness—Prednisone—gout	7.01e-05	0.000417	CcSEcCtD
Lansoprazole—Alanine aminotransferase increased—Prednisone—gout	7.01e-05	0.000417	CcSEcCtD
Lansoprazole—Rhinitis—Methylprednisolone—gout	6.96e-05	0.000414	CcSEcCtD
Lansoprazole—Diarrhoea—Naproxen—gout	6.92e-05	0.000412	CcSEcCtD
Lansoprazole—Abdominal distension—Prednisone—gout	6.91e-05	0.000411	CcSEcCtD
Lansoprazole—Hallucination—Methylprednisolone—gout	6.9e-05	0.000411	CcSEcCtD
Lansoprazole—Eye disorder—Hydrocortisone—gout	6.9e-05	0.000411	CcSEcCtD
Lansoprazole—Nausea—Allopurinol—gout	6.88e-05	0.00041	CcSEcCtD
Lansoprazole—Connective tissue disorder—Methylprednisolone—gout	6.82e-05	0.000406	CcSEcCtD
Lansoprazole—Arrhythmia—Prednisolone—gout	6.76e-05	0.000402	CcSEcCtD
Lansoprazole—Pancreatitis—Prednisone—gout	6.73e-05	0.000401	CcSEcCtD
Lansoprazole—Dizziness—Naproxen—gout	6.69e-05	0.000398	CcSEcCtD
Lansoprazole—Visual impairment—Methylprednisolone—gout	6.69e-05	0.000398	CcSEcCtD
Lansoprazole—Immune system disorder—Hydrocortisone—gout	6.67e-05	0.000397	CcSEcCtD
Lansoprazole—ABCG2—Metabolism—BCKDHA—gout	6.66e-05	0.00373	CbGpPWpGaD
Lansoprazole—Arrhythmia—Hydrocortisone—gout	6.6e-05	0.000393	CcSEcCtD
Lansoprazole—Erythema—Prednisolone—gout	6.58e-05	0.000392	CcSEcCtD
Lansoprazole—Eye disorder—Methylprednisolone—gout	6.49e-05	0.000386	CcSEcCtD
Lansoprazole—Mental disorder—Hydrocortisone—gout	6.47e-05	0.000385	CcSEcCtD
Lansoprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—gout	6.47e-05	0.00363	CbGpPWpGaD
Lansoprazole—Cardiac disorder—Methylprednisolone—gout	6.44e-05	0.000383	CcSEcCtD
Lansoprazole—Vomiting—Naproxen—gout	6.43e-05	0.000383	CcSEcCtD
Lansoprazole—Malnutrition—Hydrocortisone—gout	6.43e-05	0.000383	CcSEcCtD
Lansoprazole—Erythema—Hydrocortisone—gout	6.43e-05	0.000383	CcSEcCtD
Lansoprazole—Neutropenia—Prednisone—gout	6.42e-05	0.000382	CcSEcCtD
Lansoprazole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—gout	6.41e-05	0.0036	CbGpPWpGaD
Lansoprazole—Rash—Naproxen—gout	6.38e-05	0.00038	CcSEcCtD
Lansoprazole—Dermatitis—Naproxen—gout	6.37e-05	0.000379	CcSEcCtD
Lansoprazole—Headache—Naproxen—gout	6.34e-05	0.000377	CcSEcCtD
Lansoprazole—Erectile dysfunction—Prednisone—gout	6.32e-05	0.000376	CcSEcCtD
Lansoprazole—Angiopathy—Methylprednisolone—gout	6.3e-05	0.000375	CcSEcCtD
Lansoprazole—Immune system disorder—Methylprednisolone—gout	6.27e-05	0.000373	CcSEcCtD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	6.26e-05	0.00351	CbGpPWpGaD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	6.26e-05	0.00351	CbGpPWpGaD
Lansoprazole—Mediastinal disorder—Methylprednisolone—gout	6.25e-05	0.000372	CcSEcCtD
Lansoprazole—Weight increased—Prednisone—gout	6.25e-05	0.000372	CcSEcCtD
Lansoprazole—Vision blurred—Prednisolone—gout	6.2e-05	0.000369	CcSEcCtD
Lansoprazole—Arrhythmia—Methylprednisolone—gout	6.2e-05	0.000369	CcSEcCtD
Lansoprazole—Hyperglycaemia—Prednisone—gout	6.19e-05	0.000369	CcSEcCtD
Lansoprazole—Ill-defined disorder—Prednisolone—gout	6.11e-05	0.000364	CcSEcCtD
Lansoprazole—Mental disorder—Methylprednisolone—gout	6.08e-05	0.000362	CcSEcCtD
Lansoprazole—Erythema—Methylprednisolone—gout	6.04e-05	0.00036	CcSEcCtD
Lansoprazole—Malnutrition—Methylprednisolone—gout	6.04e-05	0.00036	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Prednisone—gout	6.04e-05	0.000359	CcSEcCtD
Lansoprazole—Angioedema—Prednisolone—gout	6.02e-05	0.000358	CcSEcCtD
Lansoprazole—Nausea—Naproxen—gout	6.01e-05	0.000358	CcSEcCtD
Lansoprazole—Myocardial infarction—Prednisone—gout	6e-05	0.000357	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Prednisone—gout	6e-05	0.000357	CcSEcCtD
Lansoprazole—Ill-defined disorder—Hydrocortisone—gout	5.97e-05	0.000355	CcSEcCtD
Lansoprazole—CYP1B1—Metabolism—PRPS1—gout	5.97e-05	0.00335	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PRPS2—gout	5.97e-05	0.00335	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—HPRT1—gout	5.97e-05	0.00335	CbGpPWpGaD
Lansoprazole—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	5.95e-05	0.00334	CbGpPWpGaD
Lansoprazole—Malaise—Prednisolone—gout	5.94e-05	0.000353	CcSEcCtD
Lansoprazole—Vertigo—Prednisolone—gout	5.92e-05	0.000352	CcSEcCtD
Lansoprazole—Syncope—Prednisolone—gout	5.9e-05	0.000351	CcSEcCtD
Lansoprazole—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	5.9e-05	0.00331	CbGpPWpGaD
Lansoprazole—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	5.88e-05	0.0033	CbGpPWpGaD
Lansoprazole—Angioedema—Hydrocortisone—gout	5.88e-05	0.00035	CcSEcCtD
Lansoprazole—Malaise—Hydrocortisone—gout	5.8e-05	0.000345	CcSEcCtD
Lansoprazole—Loss of consciousness—Prednisolone—gout	5.79e-05	0.000344	CcSEcCtD
Lansoprazole—Vertigo—Hydrocortisone—gout	5.78e-05	0.000344	CcSEcCtD
Lansoprazole—Syncope—Hydrocortisone—gout	5.77e-05	0.000343	CcSEcCtD
Lansoprazole—Convulsion—Prednisolone—gout	5.7e-05	0.000339	CcSEcCtD
Lansoprazole—Hypertension—Prednisolone—gout	5.68e-05	0.000338	CcSEcCtD
Lansoprazole—Loss of consciousness—Hydrocortisone—gout	5.65e-05	0.000336	CcSEcCtD
Lansoprazole—Ill-defined disorder—Methylprednisolone—gout	5.61e-05	0.000334	CcSEcCtD
Lansoprazole—Bradycardia—Prednisone—gout	5.59e-05	0.000333	CcSEcCtD
Lansoprazole—Convulsion—Hydrocortisone—gout	5.57e-05	0.000332	CcSEcCtD
Lansoprazole—Hypertension—Hydrocortisone—gout	5.55e-05	0.00033	CcSEcCtD
Lansoprazole—Discomfort—Prednisolone—gout	5.54e-05	0.00033	CcSEcCtD
Lansoprazole—CYP1B1—Biological oxidations—POMC—gout	5.53e-05	0.0031	CbGpPWpGaD
Lansoprazole—Angioedema—Methylprednisolone—gout	5.52e-05	0.000329	CcSEcCtD
Lansoprazole—Myalgia—Hydrocortisone—gout	5.47e-05	0.000326	CcSEcCtD
Lansoprazole—Hallucination—Prednisone—gout	5.47e-05	0.000325	CcSEcCtD
Lansoprazole—Anxiety—Hydrocortisone—gout	5.46e-05	0.000325	CcSEcCtD
Lansoprazole—Malaise—Methylprednisolone—gout	5.45e-05	0.000324	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	5.44e-05	0.000324	CcSEcCtD
Lansoprazole—Vertigo—Methylprednisolone—gout	5.43e-05	0.000323	CcSEcCtD
Lansoprazole—ABCG2—Metabolism—PRPS1—gout	5.43e-05	0.00304	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—HPRT1—gout	5.43e-05	0.00304	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PRPS2—gout	5.43e-05	0.00304	CbGpPWpGaD
Lansoprazole—Syncope—Methylprednisolone—gout	5.42e-05	0.000322	CcSEcCtD
Lansoprazole—Discomfort—Hydrocortisone—gout	5.41e-05	0.000322	CcSEcCtD
Lansoprazole—Connective tissue disorder—Prednisone—gout	5.4e-05	0.000321	CcSEcCtD
Lansoprazole—Oedema—Prednisolone—gout	5.37e-05	0.00032	CcSEcCtD
Lansoprazole—Anaphylactic shock—Prednisolone—gout	5.37e-05	0.00032	CcSEcCtD
Lansoprazole—Loss of consciousness—Methylprednisolone—gout	5.31e-05	0.000316	CcSEcCtD
Lansoprazole—Shock—Prednisolone—gout	5.29e-05	0.000315	CcSEcCtD
Lansoprazole—Oedema—Hydrocortisone—gout	5.25e-05	0.000312	CcSEcCtD
Lansoprazole—Anaphylactic shock—Hydrocortisone—gout	5.25e-05	0.000312	CcSEcCtD
Lansoprazole—CYP2C19—Phase 1 - Functionalization of compounds—POMC—gout	5.24e-05	0.00294	CbGpPWpGaD
Lansoprazole—Tachycardia—Prednisolone—gout	5.24e-05	0.000312	CcSEcCtD
Lansoprazole—Convulsion—Methylprednisolone—gout	5.23e-05	0.000312	CcSEcCtD
Lansoprazole—Hypertension—Methylprednisolone—gout	5.22e-05	0.00031	CcSEcCtD
Lansoprazole—Infection—Hydrocortisone—gout	5.21e-05	0.00031	CcSEcCtD
Lansoprazole—Hyperhidrosis—Prednisolone—gout	5.19e-05	0.000309	CcSEcCtD
Lansoprazole—Shock—Hydrocortisone—gout	5.16e-05	0.000307	CcSEcCtD
Lansoprazole—Nervous system disorder—Hydrocortisone—gout	5.15e-05	0.000306	CcSEcCtD
Lansoprazole—Myalgia—Methylprednisolone—gout	5.14e-05	0.000306	CcSEcCtD
Lansoprazole—Arthralgia—Methylprednisolone—gout	5.14e-05	0.000306	CcSEcCtD
Lansoprazole—Eye disorder—Prednisone—gout	5.14e-05	0.000306	CcSEcCtD
Lansoprazole—Anxiety—Methylprednisolone—gout	5.13e-05	0.000305	CcSEcCtD
Lansoprazole—Tachycardia—Hydrocortisone—gout	5.12e-05	0.000305	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	5.11e-05	0.000304	CcSEcCtD
Lansoprazole—Skin disorder—Hydrocortisone—gout	5.1e-05	0.000303	CcSEcCtD
Lansoprazole—Discomfort—Methylprednisolone—gout	5.08e-05	0.000302	CcSEcCtD
Lansoprazole—Hyperhidrosis—Hydrocortisone—gout	5.07e-05	0.000302	CcSEcCtD
Lansoprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—gout	5.04e-05	0.00283	CbGpPWpGaD
Lansoprazole—Anorexia—Hydrocortisone—gout	5e-05	0.000298	CcSEcCtD
Lansoprazole—Angiopathy—Prednisone—gout	4.99e-05	0.000297	CcSEcCtD
Lansoprazole—Confusional state—Methylprednisolone—gout	4.97e-05	0.000296	CcSEcCtD
Lansoprazole—Immune system disorder—Prednisone—gout	4.96e-05	0.000295	CcSEcCtD
Lansoprazole—Anaphylactic shock—Methylprednisolone—gout	4.93e-05	0.000293	CcSEcCtD
Lansoprazole—Arrhythmia—Prednisone—gout	4.91e-05	0.000292	CcSEcCtD
Lansoprazole—Hypotension—Hydrocortisone—gout	4.9e-05	0.000292	CcSEcCtD
Lansoprazole—Infection—Methylprednisolone—gout	4.9e-05	0.000292	CcSEcCtD
Lansoprazole—Insomnia—Prednisolone—gout	4.86e-05	0.000289	CcSEcCtD
Lansoprazole—Alopecia—Prednisone—gout	4.86e-05	0.000289	CcSEcCtD
Lansoprazole—Shock—Methylprednisolone—gout	4.85e-05	0.000289	CcSEcCtD
Lansoprazole—Nervous system disorder—Methylprednisolone—gout	4.84e-05	0.000288	CcSEcCtD
Lansoprazole—Paraesthesia—Prednisolone—gout	4.82e-05	0.000287	CcSEcCtD
Lansoprazole—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	4.82e-05	0.00271	CbGpPWpGaD
Lansoprazole—Mental disorder—Prednisone—gout	4.81e-05	0.000287	CcSEcCtD
Lansoprazole—Tachycardia—Methylprednisolone—gout	4.81e-05	0.000286	CcSEcCtD
Lansoprazole—Skin disorder—Methylprednisolone—gout	4.79e-05	0.000285	CcSEcCtD
Lansoprazole—Malnutrition—Prednisone—gout	4.78e-05	0.000285	CcSEcCtD
Lansoprazole—Erythema—Prednisone—gout	4.78e-05	0.000285	CcSEcCtD
Lansoprazole—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	4.78e-05	0.00268	CbGpPWpGaD
Lansoprazole—Musculoskeletal discomfort—Hydrocortisone—gout	4.78e-05	0.000285	CcSEcCtD
Lansoprazole—Hyperhidrosis—Methylprednisolone—gout	4.77e-05	0.000284	CcSEcCtD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	4.75e-05	0.00266	CbGpPWpGaD
Lansoprazole—Insomnia—Hydrocortisone—gout	4.75e-05	0.000282	CcSEcCtD
Lansoprazole—Paraesthesia—Hydrocortisone—gout	4.71e-05	0.00028	CcSEcCtD
Lansoprazole—Dyspepsia—Hydrocortisone—gout	4.62e-05	0.000275	CcSEcCtD
Lansoprazole—Hypotension—Methylprednisolone—gout	4.61e-05	0.000274	CcSEcCtD
Lansoprazole—Pain—Prednisolone—gout	4.59e-05	0.000273	CcSEcCtD
Lansoprazole—Decreased appetite—Hydrocortisone—gout	4.56e-05	0.000271	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Hydrocortisone—gout	4.53e-05	0.00027	CcSEcCtD
Lansoprazole—Fatigue—Hydrocortisone—gout	4.52e-05	0.000269	CcSEcCtD
Lansoprazole—Vision blurred—Prednisone—gout	4.51e-05	0.000268	CcSEcCtD
Lansoprazole—CYP1A1—Metabolism—BCKDHA—gout	4.51e-05	0.00253	CbGpPWpGaD
Lansoprazole—Musculoskeletal discomfort—Methylprednisolone—gout	4.49e-05	0.000267	CcSEcCtD
Lansoprazole—Pain—Hydrocortisone—gout	4.49e-05	0.000267	CcSEcCtD
Lansoprazole—Insomnia—Methylprednisolone—gout	4.46e-05	0.000265	CcSEcCtD
Lansoprazole—Ill-defined disorder—Prednisone—gout	4.44e-05	0.000264	CcSEcCtD
Lansoprazole—Feeling abnormal—Prednisolone—gout	4.43e-05	0.000264	CcSEcCtD
Lansoprazole—Paraesthesia—Methylprednisolone—gout	4.43e-05	0.000263	CcSEcCtD
Lansoprazole—Anaemia—Prednisone—gout	4.42e-05	0.000263	CcSEcCtD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	4.41e-05	0.00248	CbGpPWpGaD
Lansoprazole—Agitation—Prednisone—gout	4.4e-05	0.000262	CcSEcCtD
Lansoprazole—Angioedema—Prednisone—gout	4.37e-05	0.00026	CcSEcCtD
Lansoprazole—Dyspepsia—Methylprednisolone—gout	4.34e-05	0.000258	CcSEcCtD
Lansoprazole—Feeling abnormal—Hydrocortisone—gout	4.32e-05	0.000257	CcSEcCtD
Lansoprazole—Malaise—Prednisone—gout	4.31e-05	0.000257	CcSEcCtD
Lansoprazole—Vertigo—Prednisone—gout	4.3e-05	0.000256	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Hydrocortisone—gout	4.29e-05	0.000255	CcSEcCtD
Lansoprazole—Syncope—Prednisone—gout	4.29e-05	0.000255	CcSEcCtD
Lansoprazole—Urticaria—Prednisolone—gout	4.27e-05	0.000254	CcSEcCtD
Lansoprazole—Fatigue—Methylprednisolone—gout	4.25e-05	0.000253	CcSEcCtD
Lansoprazole—Loss of consciousness—Prednisone—gout	4.2e-05	0.00025	CcSEcCtD
Lansoprazole—Urticaria—Hydrocortisone—gout	4.17e-05	0.000248	CcSEcCtD
Lansoprazole—Abdominal pain—Hydrocortisone—gout	4.15e-05	0.000247	CcSEcCtD
Lansoprazole—Body temperature increased—Hydrocortisone—gout	4.15e-05	0.000247	CcSEcCtD
Lansoprazole—Convulsion—Prednisone—gout	4.15e-05	0.000247	CcSEcCtD
Lansoprazole—CYP2C8—Metabolism—BCKDHA—gout	4.13e-05	0.00232	CbGpPWpGaD
Lansoprazole—Hypertension—Prednisone—gout	4.13e-05	0.000246	CcSEcCtD
Lansoprazole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—gout	4.09e-05	0.00229	CbGpPWpGaD
Lansoprazole—Arthralgia—Prednisone—gout	4.07e-05	0.000242	CcSEcCtD
Lansoprazole—Myalgia—Prednisone—gout	4.07e-05	0.000242	CcSEcCtD
Lansoprazole—Feeling abnormal—Methylprednisolone—gout	4.06e-05	0.000242	CcSEcCtD
Lansoprazole—Anxiety—Prednisone—gout	4.06e-05	0.000242	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	4.05e-05	0.000241	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Methylprednisolone—gout	4.03e-05	0.00024	CcSEcCtD
Lansoprazole—Discomfort—Prednisone—gout	4.02e-05	0.00024	CcSEcCtD
Lansoprazole—Hypersensitivity—Prednisolone—gout	3.96e-05	0.000236	CcSEcCtD
Lansoprazole—Urticaria—Methylprednisolone—gout	3.92e-05	0.000233	CcSEcCtD
Lansoprazole—Oedema—Prednisone—gout	3.9e-05	0.000232	CcSEcCtD
Lansoprazole—Anaphylactic shock—Prednisone—gout	3.9e-05	0.000232	CcSEcCtD
Lansoprazole—Abdominal pain—Methylprednisolone—gout	3.9e-05	0.000232	CcSEcCtD
Lansoprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	3.89e-05	0.00218	CbGpPWpGaD
Lansoprazole—Infection—Prednisone—gout	3.88e-05	0.000231	CcSEcCtD
Lansoprazole—Hypersensitivity—Hydrocortisone—gout	3.87e-05	0.00023	CcSEcCtD
Lansoprazole—Shock—Prednisone—gout	3.84e-05	0.000229	CcSEcCtD
Lansoprazole—Nervous system disorder—Prednisone—gout	3.83e-05	0.000228	CcSEcCtD
Lansoprazole—Tachycardia—Prednisone—gout	3.81e-05	0.000227	CcSEcCtD
Lansoprazole—Skin disorder—Prednisone—gout	3.79e-05	0.000226	CcSEcCtD
Lansoprazole—Hyperhidrosis—Prednisone—gout	3.77e-05	0.000225	CcSEcCtD
Lansoprazole—Asthenia—Hydrocortisone—gout	3.77e-05	0.000224	CcSEcCtD
Lansoprazole—Anorexia—Prednisone—gout	3.72e-05	0.000222	CcSEcCtD
Lansoprazole—Pruritus—Hydrocortisone—gout	3.71e-05	0.000221	CcSEcCtD
Lansoprazole—CYP2C19—Metabolism—BCKDHA—gout	3.69e-05	0.00207	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PRPS2—gout	3.67e-05	0.00206	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PRPS1—gout	3.67e-05	0.00206	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—HPRT1—gout	3.67e-05	0.00206	CbGpPWpGaD
Lansoprazole—Hypersensitivity—Methylprednisolone—gout	3.63e-05	0.000216	CcSEcCtD
Lansoprazole—ABCB1—Metabolism—BCKDHA—gout	3.6e-05	0.00202	CbGpPWpGaD
Lansoprazole—Diarrhoea—Hydrocortisone—gout	3.59e-05	0.000214	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Prednisone—gout	3.56e-05	0.000212	CcSEcCtD
Lansoprazole—Dizziness—Prednisolone—gout	3.55e-05	0.000211	CcSEcCtD
Lansoprazole—Asthenia—Methylprednisolone—gout	3.54e-05	0.000211	CcSEcCtD
Lansoprazole—Insomnia—Prednisone—gout	3.53e-05	0.00021	CcSEcCtD
Lansoprazole—Paraesthesia—Prednisone—gout	3.51e-05	0.000209	CcSEcCtD
Lansoprazole—Pruritus—Methylprednisolone—gout	3.49e-05	0.000208	CcSEcCtD
Lansoprazole—Dizziness—Hydrocortisone—gout	3.47e-05	0.000207	CcSEcCtD
Lansoprazole—Dyspepsia—Prednisone—gout	3.44e-05	0.000205	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism—ABCG2—gout	3.43e-05	0.00192	CbGpPWpGaD
Lansoprazole—CYP1A1—Biological oxidations—POMC—gout	3.4e-05	0.00191	CbGpPWpGaD
Lansoprazole—Decreased appetite—Prednisone—gout	3.39e-05	0.000202	CcSEcCtD
Lansoprazole—CYP2D6—Metabolism—BCKDHA—gout	3.39e-05	0.0019	CbGpPWpGaD
Lansoprazole—Rash—Prednisolone—gout	3.39e-05	0.000202	CcSEcCtD
Lansoprazole—Dermatitis—Prednisolone—gout	3.38e-05	0.000201	CcSEcCtD
Lansoprazole—Diarrhoea—Methylprednisolone—gout	3.37e-05	0.000201	CcSEcCtD
Lansoprazole—CYP2C8—Metabolism—PRPS1—gout	3.37e-05	0.00189	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HPRT1—gout	3.37e-05	0.00189	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PRPS2—gout	3.37e-05	0.00189	CbGpPWpGaD
Lansoprazole—Fatigue—Prednisone—gout	3.37e-05	0.0002	CcSEcCtD
Lansoprazole—Headache—Prednisolone—gout	3.37e-05	0.0002	CcSEcCtD
Lansoprazole—CYP2C9—Metabolism—BCKDHA—gout	3.36e-05	0.00189	CbGpPWpGaD
Lansoprazole—Constipation—Prednisone—gout	3.34e-05	0.000199	CcSEcCtD
Lansoprazole—Vomiting—Hydrocortisone—gout	3.34e-05	0.000199	CcSEcCtD
Lansoprazole—Rash—Hydrocortisone—gout	3.31e-05	0.000197	CcSEcCtD
Lansoprazole—Dermatitis—Hydrocortisone—gout	3.31e-05	0.000197	CcSEcCtD
Lansoprazole—CYP4A11—Metabolism of lipids and lipoproteins—POMC—gout	3.29e-05	0.00185	CbGpPWpGaD
Lansoprazole—Headache—Hydrocortisone—gout	3.29e-05	0.000196	CcSEcCtD
Lansoprazole—Dizziness—Methylprednisolone—gout	3.26e-05	0.000194	CcSEcCtD
Lansoprazole—Feeling abnormal—Prednisone—gout	3.22e-05	0.000191	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Prednisone—gout	3.19e-05	0.00019	CcSEcCtD
Lansoprazole—Nausea—Prednisolone—gout	3.19e-05	0.00019	CcSEcCtD
Lansoprazole—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	3.15e-05	0.00177	CbGpPWpGaD
Lansoprazole—Vomiting—Methylprednisolone—gout	3.13e-05	0.000187	CcSEcCtD
Lansoprazole—CYP2C8—Biological oxidations—POMC—gout	3.12e-05	0.00175	CbGpPWpGaD
Lansoprazole—Nausea—Hydrocortisone—gout	3.12e-05	0.000186	CcSEcCtD
Lansoprazole—Rash—Methylprednisolone—gout	3.11e-05	0.000185	CcSEcCtD
Lansoprazole—Dermatitis—Methylprednisolone—gout	3.11e-05	0.000185	CcSEcCtD
Lansoprazole—Urticaria—Prednisone—gout	3.1e-05	0.000185	CcSEcCtD
Lansoprazole—Headache—Methylprednisolone—gout	3.09e-05	0.000184	CcSEcCtD
Lansoprazole—Abdominal pain—Prednisone—gout	3.09e-05	0.000184	CcSEcCtD
Lansoprazole—Body temperature increased—Prednisone—gout	3.09e-05	0.000184	CcSEcCtD
Lansoprazole—CYP2C19—Metabolism—PRPS2—gout	3.01e-05	0.00169	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HPRT1—gout	3.01e-05	0.00169	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PRPS1—gout	3.01e-05	0.00169	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—ABCG2—gout	2.99e-05	0.00168	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PRPS2—gout	2.93e-05	0.00165	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HPRT1—gout	2.93e-05	0.00165	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PRPS1—gout	2.93e-05	0.00165	CbGpPWpGaD
Lansoprazole—Nausea—Methylprednisolone—gout	2.93e-05	0.000174	CcSEcCtD
Lansoprazole—Hypersensitivity—Prednisone—gout	2.88e-05	0.000171	CcSEcCtD
Lansoprazole—CYP1A2—Metabolism—BCKDHA—gout	2.87e-05	0.00161	CbGpPWpGaD
Lansoprazole—Asthenia—Prednisone—gout	2.8e-05	0.000167	CcSEcCtD
Lansoprazole—CYP2C19—Biological oxidations—POMC—gout	2.79e-05	0.00156	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PRPS2—gout	2.76e-05	0.00155	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HPRT1—gout	2.76e-05	0.00155	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PRPS1—gout	2.76e-05	0.00155	CbGpPWpGaD
Lansoprazole—Pruritus—Prednisone—gout	2.76e-05	0.000164	CcSEcCtD
Lansoprazole—CYP2C9—Metabolism—PRPS1—gout	2.74e-05	0.00154	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PRPS2—gout	2.74e-05	0.00154	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HPRT1—gout	2.74e-05	0.00154	CbGpPWpGaD
Lansoprazole—Diarrhoea—Prednisone—gout	2.67e-05	0.000159	CcSEcCtD
Lansoprazole—Dizziness—Prednisone—gout	2.58e-05	0.000154	CcSEcCtD
Lansoprazole—CYP2D6—Biological oxidations—POMC—gout	2.56e-05	0.00144	CbGpPWpGaD
Lansoprazole—CYP2C9—Biological oxidations—POMC—gout	2.54e-05	0.00142	CbGpPWpGaD
Lansoprazole—Vomiting—Prednisone—gout	2.48e-05	0.000148	CcSEcCtD
Lansoprazole—Rash—Prednisone—gout	2.46e-05	0.000147	CcSEcCtD
Lansoprazole—Dermatitis—Prednisone—gout	2.46e-05	0.000146	CcSEcCtD
Lansoprazole—Headache—Prednisone—gout	2.45e-05	0.000146	CcSEcCtD
Lansoprazole—CYP1A2—Metabolism—PRPS1—gout	2.34e-05	0.00131	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HPRT1—gout	2.34e-05	0.00131	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PRPS2—gout	2.34e-05	0.00131	CbGpPWpGaD
Lansoprazole—Nausea—Prednisone—gout	2.32e-05	0.000138	CcSEcCtD
Lansoprazole—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	2.32e-05	0.0013	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—BCKDHA—gout	2.22e-05	0.00124	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—ABCG2—gout	2.21e-05	0.00124	CbGpPWpGaD
Lansoprazole—CYP1A2—Biological oxidations—POMC—gout	2.17e-05	0.00122	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism of lipids and lipoproteins—POMC—gout	2.12e-05	0.00119	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PRPS1—gout	1.81e-05	0.00101	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PRPS2—gout	1.81e-05	0.00101	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HPRT1—gout	1.81e-05	0.00101	CbGpPWpGaD
Lansoprazole—CYP3A4—Biological oxidations—POMC—gout	1.68e-05	0.00094	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—POMC—gout	1.47e-05	0.000823	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ABCG2—gout	1.36e-05	0.000763	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—gout	1.31e-05	0.000733	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—POMC—gout	1.28e-05	0.000719	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ABCG2—gout	1.25e-05	0.000699	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	1.2e-05	0.000672	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ABCG2—gout	1.11e-05	0.000624	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ABCG2—gout	1.09e-05	0.000609	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—gout	1.07e-05	0.0006	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ABCG2—gout	1.02e-05	0.000574	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ABCG2—gout	1.01e-05	0.000569	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	9.75e-06	0.000547	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—POMC—gout	9.45e-06	0.00053	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ABCG2—gout	8.67e-06	0.000486	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—POMC—gout	8.6e-06	0.000482	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—gout	8.34e-06	0.000468	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ABCG2—gout	6.69e-06	0.000375	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—POMC—gout	5.82e-06	0.000327	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—POMC—gout	5.34e-06	0.000299	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—POMC—gout	4.76e-06	0.000267	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—POMC—gout	4.65e-06	0.000261	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—POMC—gout	4.38e-06	0.000246	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—POMC—gout	4.34e-06	0.000244	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—POMC—gout	3.71e-06	0.000208	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—POMC—gout	2.87e-06	0.000161	CbGpPWpGaD
